1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 2-8, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 2-8, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs

Event Date: 08/05/2026
Location: Silver Spring, MD
Subject: MDUFA VI Agreement 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sean R. Keveney, J.D., Chief Counsel

Event Date: 08/07/2026
Location: Washington, DC 
Subject: Capricor
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Elizabeth Richard, John Manthei (Latham & Watkins LLP);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 08/04/2026
Location: Virtual
Subject: Homeopathic Remedies
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: All Better Health representatives

Event Date: 08/05/2026
Location: Virtual
Subject: Premium Cigar Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Cigar Rights of America (CRA) representatives

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 08/05/2026
Location: Virtual
Subject: Glycogen Storage Disease Type Ia (GSDIa) Program Meeting
FDA Participant/Group: KARIM MIKHAIL; 
Non FDA Participant/Group: Eric Crombez (Ultragenyx);

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food

Event Date: 08/05/2026
Location: Virtual 
Subject: Infant Formula and Toddler Nutrition Issues of Mutual Interest
FDA Participant/Group: KRISTI MULDOON JACOBS; REBECCA BUCKNER; PETER KOUFOPOULOS; KRISTIN GARCIA; LARRY MORRIS; BENJAMIN WARREN; 
Non FDA Participant/Group: Infant Nutrition Council of America representatives

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 08/04/2026
Location: Silver Spring, MD
Subject: Innovative Therapies for Individuals Living With Type 1 Diabetes
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Aaron J. Kowalski (Breakthrough T1D);

Event Date: 08/07/2026
Location: Virtual
Subject: American Medical Progress (AMP) / People for Effective and Ethical Research (PEER) Coalition Introductory Meeting
FDA Participant/Group: HALEH SABER; SCOTT STEELE; 
Non FDA Participant/Group: Naomi Charalambakis (American Medical Progress);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top